Todos Med Ltd (TOMDF)

[DreyDreyDrey]

GC and the board have a SP target number that will trigger the RS for up listing. It is not .017 cents. Or they would have done it. If I had to guess, it is at least .10 cents sustained for a month. More likely .20 cents sustained for 2 months. But I can believe it could be as high as .30 cents sustained for a few months. If they RS while the company is weak. It could be a disaster with the stock dropping down below $2 in a month. And all of the upside lost.

The only thing that is going to raise the SP up that high is great news AND good solid financials. Like an EUA for Covid treatment. Monkey Pox oral test EUA. Cancer test phase 3 approval AND Alzheimer’s test phase 3 approval (so much great news people will ignore the financials). Or phase 3 approval of one of the tests with a noticeable uptick in sales. I would say $8,000,000 in revenue without higher spending. That would point the balance sheet in a very positive direction. Approaching profitability. Basically losing a lot less money.

The RS and up listing launched on the strong boost of news like any of those events. Could be a force multiplier. People see real progress. Real numbers. And a few funds jump in. I believe all of the shorts have to cover during the up listing. And last, I could be making this up, I have heard it many times from different people, mostly just amateur investors. But never really researched it. I believe it is harder for shorts to play dirty on the bigger boards. More rules. More people watching. So less shenanigans. More stable SP.

What I would appreciate someone explaining to me is what happens to the 4 billion approved but unissued shares. Are they reduced proportionally with the RS? Or does Todos come out the other side with 4 billion shares and a $5 stock price?